Connect with us

Hi, what are you looking for?

Editor's Pick

Scalise temporarily leaves Washington for stem cell treatment

House Majority Leader Steve Scalise (R-La.) will be away from Washington until February so he can receive a stem cell transplant as part of his treatment for blood cancer, further dwindling the House Republicans’ narrow majority.

Scalise’s temporary absence comes as the House is facing down significant deadlines. There’s a partial government shutdown looming over Washington, with House Republicans threatening to oppose federal funding for crucial government services and aid to Ukraine unless Congress enacts strict changes to border security laws. Funding for roughly 20 percent of the federal government expires Jan. 19, and money for the rest of the government runs out Feb. 2.

Another Republican, Rep. Bill Johnson (Ohio) is retiring later this month to lead Youngstown State University — narrowing the House GOP’s bench further. That means Speaker Mike Johnson (R-La.) can only afford to lose two members of his party to pass any legislation, or rely on Democratic support for measures.

Passing consequential bills with the support of Democrats, especially involving government funding, has greatly irked hard-line Republicans, who ousted former Rep. Kevin McCarthy (R-Calif.) from the speakership and put Johnson on notice.

McCarthy retired at the end of December after being removed from his leadership role in an effort instigated by far-right members of his conference. Former Rep. George Santos (R-N.Y.) was expelled from Congress last month, too.

Scalise was nominated by a majority of the GOP conference to replace McCarthy as speaker last fall, but he ultimately could not clinch the necessary 218 votes from Republicans on the House floor for reasons, including worries that his health could hurt his ability to travel to fundraise for candidates during a busy election season. Scalise has since served as a leadership mentor for Johnson, a fellow Louisianian, who ascended quickly from the rank-and-file to the speakership.

Scalise’s office said in a statement on Friday that in December, he “successfully completed induction chemotherapy and had a positive response.”

“It has now been determined he is eligible for an autologous stem cell transplant. He is currently undergoing the transplant process, marking a significant milestone in his battle against cancer. Once the procedure is completed, he will be recovering under the supervision of his medical team and will work remotely until returning to Washington next month,” the statement continued.

Scalise announced in August that he was diagnosed with multiple myeloma, a treatable, rare form of blood cancer.

As majority leader, Scalise is the No. 2 Republican in the chamber. A former Louisiana state lawmaker, Scalise has served in Congress since 2008 and is running for reelection for his ninth full term.

Multiple myeloma occurs in plasma cells — the white blood cells that help fight infections by making antibodies that attack germs — according to Mayo Clinic. In someone with multiple myeloma, these cancerous cells grow out of control, accumulating in the bone marrow and crowding out healthy blood cells.

Scalise’s procedure involves using stem cells from one’s own body, which are transplanted back into a patient’s bone marrow after chemotherapy, according to the M.D. Anderson Cancer Center. Infection risk is high after the procedure. Patients also face risks of bleeding and anemia. Normal blood counts, according to the center, are expected to return within two to four weeks and patients typically return to normal activities within three to six months.

Scalise has overcome serious medical challenges before, particularly in 2017 after he was shot and critically wounded when a gunman opened fire at a GOP practice for the Congressional Baseball Game. Scalise was shot in the left hip, requiring several surgeries to deal with fractured bones, injured internal organs and severe bleeding.

Amy B Wang and Laurie McGinley contributed to this report.

This post appeared first on The Washington Post

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Investing

    I experimented with various strategies that mainly involved long options, which would eventually depreciate and eat away at my capital.   How to start...

    Latest News

    A 23-year-old German-Israeli woman who was kidnapped from the Nova music festival by Hamas militants on October 7 has been declared dead, the Israeli...

    Investing

    (Most traded options are American options. The underlying can be bought or sold anytime . However ‘European’ options, which can only be exercised on...

    Editor's Pick

    IoT Complete is a fast and easy way to connect products. The fully integrated service enables enterprises to connect their products from certified connectivity...

    Disclaimer: gorgeousincome.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 gorgeousincome.com